GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹36 Cr | ₹240 Cr | ₹1,441 Cr | ₹1,382 Cr | ₹1,096 Cr |
What is the latest Profit Before Tax of GLENMARK PHARMACEUTICALS ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹240 Cr |
| Mar2023 | ₹1,441 Cr |
| Mar2022 | ₹1,382 Cr |
| Mar2021 | ₹1,096 Cr |
How is Profit Before Tax of GLENMARK PHARMACEUTICALS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | -84.78 | |
| Mar2024 | ₹240 Cr | -83.36 | |
| Mar2023 | ₹1,441 Cr | 4.25 | |
| Mar2022 | ₹1,382 Cr | 26.13 | |
| Mar2021 | ₹1,096 Cr | - | |
Compare Profit Before Tax of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,130.0 Cr | 7.7% | 15.1% | 60.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 7.7% |
15.1% |
60.7% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses